Publications by authors named "Robert Jurgen van 't Hof"
Article Synopsis
- Osteoporosis is a common age-related disorder marked by low bone mass and increased fracture risk, with limited anabolic treatment options.
- Research shows that Syndecan-3 (Sdc3) boosts new bone formation by enhancing WNT signaling, highlighting its potential for treating osteoporosis.
- In experiments, overexpressing Sdc3 in osteoblasts improved bone volume in both Sdc3-deficient mice and wild-type mice, suggesting it could be a viable target for developing new bone-building drugs.
